Full-Time

Head of Culture & Belonging

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior, Expert

Somerset County, NJ, USA

Hybrid position.

Category
Human Resources
People & HR
Requirements
  • Bachelor’s degree in Human Resources, Organizational Development, Business Administration, Psychology, or a related field. Advanced degree preferred.
  • 10+ years of experience in human resources, organizational development, or a related field, with a strong focus on culture and employee engagement.
  • Demonstrated experience in successfully building and delivering diversity, equity, inclusion and accessibility programs and activities.
  • Strong understanding of organizational culture, DE&I practices and its impact on business performance.
  • Excellent communication, interpersonal, and facilitation skills.
  • Ability to work collaboratively with diverse teams and manage complex change initiatives.
Responsibilities
  • Design and execute strategies to drive culture transformation
  • Align cultural initiatives with business objectives and organizational values.
  • Serve as a culture champion and advisor to senior leadership on cultural issues and initiatives.
  • Foster a positive, inclusive, and innovative work environment across all levels of the organization.
  • Lead initiatives that enhance employee engagement, satisfaction, and retention.
  • Track and measure the effectiveness of cultural initiatives and programs through qualitative and quantitative metrics.
  • Report on culture-related KPIs and provide insights and recommendations to leadership.
  • Lead & drive company EVP and employer branding programs with positive impact
  • Develop and oversee programs that promote cultural integration, diversity, equity, and inclusion with positive impact

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates within the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

20%

1 year growth

47%

2 year growth

106%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.

Help us improve and share your feedback! Did you find this helpful?